{
    "nctId": "NCT03613181",
    "briefTitle": "ANG1005 in Leptomeningeal Disease From Breast Cancer",
    "officialTitle": "A Randomized Open-Label, Multi-Center Pivotal Study of ANG1005 Compared With Physician's Best Choice in HER2-Negative Breast Cancer Patients With Newly Diagnosed Leptomeningeal Carcinomatosis and Previously Treated Brain Metastases (ANGLeD)",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Leptomeningeal Carcinomatosis, Leptomeningeal Metastases, Brain Metastases, HER2-negative Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 150,
    "primaryOutcomeMeasure": "Overall survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. \u2265 18 years old\n2. HER2-negative breast cancer\n3. At least 2 months of expected survival\n4. Newly diagnosed leptomeningeal carcinomatosis\n5. Documented history of brain metastasis that has been previously treated with radiation therapy\n6. Neurologically stable\n7. Eastern Cooperative Oncology Group performance status grade \u22642\n8. Adequate laboratory test results prior to first dose\n9. Patients who are fertile must agree to remain abstinent or use reliable method of birth control\n\nExclusion Criteria:\n\n1. Any prior treatment for leptomeningeal carcinomatosis, except emergency radiotherapy or shunt\n2. Prior treatment with ANG1005\n3. Patients who have not had radiotherapy for their brain metastases\n4. Evidence of symptomatic intracranial hemorrhage or increased intracranial pressure\n5. Patients for whom intrathecal therapy is the most appropriate therapy for leptomeningeal disease\n6. Pregnancy or lactation and patients planning to be pregnant during the study\n7. Peripheral neuropathy \\> Grade 2\n8. Evidence of severe or uncontrolled diseases\n9. Presence of an infection including abscess or fistulae, or known infection with hepatitis B or C or HIV\n10. History of interstitial lung disease\n11. Severe conduction disturbance\n12. Central nervous system disease requiring immediate neurosurgical intervention\n13. Known allergy to paclitaxel or any of its components\n14. Contra-indication for contrast-enhanced MRI",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}